Funding Announcement
The digital healthcare platform Evaro has successfully completed a $25 million (£18 million) Series A funding round aimed at enhancing its healthcare-as-a-service model.
Company Background
Founded in 2018 by emergency physician Dr. Thuria Wenbar and pharmacist researcher Dr. Oskar Wenbar, Evaro targets three key markets:
- Consumer brands seeking new revenue opportunities
- Healthcare providers looking to expand digital services for common conditions
- Employers offering health benefits to their employees
Partnerships and Services
Evaro, which is licensed by the NHS, collaborates with:
- Clue – a period-tracking app
- Lovehoney – a sexual wellness retailer
These partnerships allow Evaro to integrate prescription services directly into their customer experiences.
Funding Utilization
The newly acquired funds will be allocated to:
- Enhancing the healthcare-as-a-service model
- Expanding services in women’s health, men’s health, and longevity medicine
- Improving clinical capabilities and platform development
CEO’s Statement
Dr. Thuria Wenbar, CEO and co-founder, emphasized the need for alternative healthcare solutions, stating:
“When a third of people are waiting over a week just to see their GP, it’s time to think through alternative solutions that help people get the care they need while supporting NHS capacity.”
She added, “We’re making healthcare as accessible as online banking, and this funding lets us prove that model works at scale.”
Impact on NHS
Evaro aims to reduce the strain on the NHS by providing a comprehensive regulated healthcare infrastructure that can be integrated into various platforms. This includes:
- Asynchronous consultations
- Remote diagnostics
- Prescribing and dispensing
- Aftercare services
Future Goals
The company aims to serve 10 million patients over the next three years, addressing the growing demand for accessible healthcare solutions.
Funding Details
The funding round was led by AlbionVC, with contributions from:
- Simplyhealth Ventures
- Exceptional Ventures
- Cornerstone VC
- BBI
Christoph Ruedig, partner at AlbionVC, remarked on Evaro’s potential, stating:
“We’ve seen embedded finance transform banking; Evaro is now driving the embedded health revolution.”